Home/ Stocks/ ATRA

Atara Biotherapeutics, Inc

ATRA XNAS

$9.38 -0.31 (-3.20%) ▼ 15-min delayed

Open

$9.69

High

$9.92

Low

$9.30

Volume

29.7K

Market Cap

$97.27M

About Atara Biotherapeutics, Inc

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 10 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$630.0K	$-4,834,000	$-0.32
Q1 2026	$516.0K	$-4,145,000	$-0.29
FY 2025	$120.77M	$32.69M	$2.61
Q3 2025	$3.45M	$-4,303,000	$-0.32

Earnings & Analyst Ratings

Next Earnings: Tue, Nov 10, 2026

Calendar →

Related Market News

No specific coverage for ATRA yet. Check out our latest market news or earnings calendar.

Get ATRA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Atara Biotherapeutics, Inc.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.